Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Xencor, Inc. is a biopharmaceutical company specializing in engineered antibody therapeutics for cancer and autoimmune diseases. Its core focus is on protein engineering to develop bispecific and multi-specific antibodies with enhanced properties. The company’s portfolio includes clinical-stage drug candidates and licensed medicines, leveraging proprietary Fc domain technologies to improve efficacy, half-life, and safety, primarily targeting oncology and inflammatory conditions worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.